Ampio Pharmaceuticals Inc

ASE:AMPE   3:59:50 PM EDT
0.00 (+0.80%)
Earnings Announcements

Ampio Pharmaceuticals Reports Fourth-Quarter Financial Results

Published: 03/29/2022 20:20 GMT
Ampio Pharmaceuticals Inc (AMPE) - Ampio Pharmaceuticals Reports Fourth-quarter and Full-year 2021 Financial Results and Operational Highlights.
Ampio Pharmaceuticals Inc - Cash and Cash Equivalents of $34 Million Expected to Fund Current Operations Into 2h 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.02

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.02

More details on our Analysts Page.